Oncotarget: Adoptive cell therapy in combination with checkpoint inhibitors Bioengineer, 10 Jun 2020 Volume 11, Issue 22 of @Oncotarget reported that there are rationale and evidence supporting immune therapy in Ovarian Cancers.